The fund normally invests at least 80% of its net assets (including borrowings for investment purposes) in the equity securities that comprise the index. The index seeks to provide opportunistic investment exposure to those stocks with the potential to "break out," or experience a period of sustained price growth beyond the stock’s recent “resistance level,” with consideration for various market conditions. The fund is non-diversified.

Glaukos Corporation

Enliven Therapeutics, Inc.

Bicara Therapeutics Inc. Common Stock

U.S. Bancorp

Liquidia Corporation

Tapestry, Inc.

Oscar Health, Inc.

The PNC Financial Services Group, Inc.

TG Therapeutics, Inc.

Dave Inc.

Financial Services

Healthcare

Consumer Cyclical

Industrials

Energy

Consumer Defensive

Technology

CapForce IBD Breakout Opportunities ETF

BOUT Holdings & Sector Breakdown